SCHEMBL4746385

SCHEMBL4746385

c1ccc(-c2ccc3c(c2)c(-c2ccc4ccc(-c5cc6c7ccc(-c8ccccc8)c8c7c(cc6c6ccc(-c7ccccc7)cc56)-c5ncccc5-8)cc4c2)cc2c4ccc(-c5ccccc5)c5c4c(cc32)-c2ncccc2-5)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.34
MAP4K4 O95819 1/20 0.33
TYK2 P29597 1/20 0.33
MINK1 Q8N4C8 1/20 0.33
SRPK1 Q96SB4 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
PIK3CA P42336 1/20 0.33
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
CYP17A1 P05093 1/20 0.32
CYP19A1 P11511 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
PLG P00747 1/20 0.31
PLAU P00749 1/20 0.31
GPR84 Q9NQS5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746391 0.97 FEN1 (0.34) FEN1MAP4K4TYK2MINK1SRPK1
SCHEMBL4746316 0.93 PIK3CA (0.36) FEN1MAP4K4PIK3CAPTGS1PTGS2
SCHEMBL4746334 0.93 PIK3CA (0.36) FEN1MAP4K4PIK3CAPTGS1PTGS2
SCHEMBL4746325 0.92 FEN1 (0.35) FEN1MAP4K4PIK3CAPTGS1PTGS2
SCHEMBL4746330 0.92 FEN1 (0.35) FEN1MAP4K4PIK3CAPTGS1PTGS2
SCHEMBL4746366 0.89 PIK3CA (0.35) FEN1PIK3CAPTGS1PTGS2TOP1
SCHEMBL4746378 0.88 PIK3CA (0.34) FEN1PIK3CAPTGS1PTGS2TOP1
SCHEMBL4746453 0.88 PIK3CA (0.34) FEN1PIK3CAPTGS1PTGS2TOP1
SCHEMBL4746003 0.88 PIK3CA (0.34) FEN1PIK3CAPTGS1PTGS2TOP1
SCHEMBL4746468 0.87 PIK3CA (0.34) FEN1PIK3CAPTGS1PTGS2TOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 FEN1 1309/4885MAP4K4 4127/4885TYK2 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.